Concepedia

Author

Ilka Schellschmidt

Bayer (Germany)

Also Known As

I Schellschmidt, I. Schellschmidt, Ilka Schellschmidt, Schürmann, R.

16

Publications

686

Citations

9

H-Index

35

Concepts

All Affiliations

Bayer (Germany)Berlin Center for Epidemiology and Health Research
IS

About

Ilka Schellschmidt is an author at Bayer (Germany) specializing in medicine, obstetrics, and contraception.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

598

2

Obstetrics

6

6

504

3

Public Health

3

3

394

4

Endocrinology

2

2

220

5

Health Policy

1

1

76

Ilka Schellschmidt

×

9

Publications

672

Citations

9

H-Index

YearCitations

A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena

Kristina Gemzell‐Danielsson, Ilka Schellschmidt, Dan Apter

Fertility and Sterility

2012

192

An Effective Hormonal Male Contraceptive Using Testosterone Undecanoate with Oral or Injectable Norethisterone Preparations

Axel Kamischke, Tanja Heuermann, Kathrin Krüger,

The Journal of Clinical Endocrinology & Metabolism

2002

126

Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.

lan H Thorneycroft, H Gollnick, Ilka Schellschmidt

PubMed

2004

94

Oral contraceptive effectiveness according to body mass index, weight, age, and other factors

Jürgen Dinger, Maureen Cronin, Sabine Möhner,

American Journal of Obstetrics and Gynecology

2009

76

Rate of Pregnancy After Using Drospirenone and Other Progestin-Containing Oral Contraceptives

Maureen Cronin, Ilka Schellschmidt, Jürgen Dinger

Obstetrics and Gynecology

2009

53

Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate

Ernesta Palombo‐Kinne, Ilka Schellschmidt, Ulrike Schumacher,

Contraception

2008

44

The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days

Jean‐Michel Foidart, Patricia J. Sulak, Ilka Schellschmidt,

Contraception

2005

40

Prognostic Significance of DNA Content and S-Phase Fraction in Epithelial Ovarian Carcinomas Analyzed by Image Cytometry

Angela Reles, Conway Gee, Ilka Schellschmidt,

Gynecologic Oncology

1998

26

Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population

Christoph Gerlinger, James Trussell, Uwe Mellinger,

Contraception

2014

21

Page 1